Patents by Inventor Timothy Connors

Timothy Connors has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240112100
    Abstract: An example device includes a user interface component that implements a user interface and receives a visualization request value from user operations; an inspection database comprising an aggregation of inspection data; and a controller, comprising: a facility planning circuit that interprets a user facility visualization value in response to the visualization request value; a facility inspection data circuit that interprets the aggregation of inspection data in response to the user facility visualization value; a geographic depiction circuit that determines a geographic display boundary and a hierarchical inspection presentation for at least one industrial facility positioned within the geographic display boundary in response to the user facility visualization value and the aggregation of inspection data, and determines a user geographic display value in response to the geographic display boundary and the hierarchical inspection presentation.
    Type: Application
    Filed: October 2, 2023
    Publication date: April 4, 2024
    Inventors: Edward A. Bryner, Richard Ducott, William Barley, Patrick Celentano, Christopher Connor Hazen, Mark Jacob Loosararian, Troy Demmer, Timothy R. Yousaf, Thomas J. Fiorelli
  • Publication number: 20090163424
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF? by administering a TNF? antagonist, such as recombinant TNFR:Fc.
    Type: Application
    Filed: February 27, 2009
    Publication date: June 25, 2009
    Applicant: IMMUNEX CORPORATION
    Inventors: Barbara K. FINCK, Larry O'Neal, John D. Pluenneke, Timothy Connor
  • Publication number: 20080044833
    Abstract: This invention provides a method for diagnosing or prognosing ovarian cancer by detecting the level of expression of pyruvate kinase isoenzyme M2 or fragment thereof in a subject. Applicants report that overexpression of this protein or fragment thereof is correlative with the presence of ovarian cancer in mammals. Applicants also report that overexpression of the protein is not correlative with the presence of an immune response, e.g., the generation of anti-PKM2 antibodies detected by Western blot analysis. Also provided are diagnostic kits and methods to assay for new candidate drugs that treat or ameliorate the symptoms associated with ovarian cancer.
    Type: Application
    Filed: May 16, 2007
    Publication date: February 21, 2008
    Inventor: Timothy Connors
  • Patent number: 7250695
    Abstract: A power control circuit is used to control the power supplied to a circuit from a power source. The power control circuit is operable to connect and disconnect the power source from the circuit. The power control circuit connects the power source to the circuit in response to an externally applied magnetic field.
    Type: Grant
    Filed: October 31, 2003
    Date of Patent: July 31, 2007
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Timothy Connors, Geoffrey Martin Lyon, Salil Pradhan
  • Publication number: 20050093374
    Abstract: A power control circuit is used to control the power supplied to a circuit from a power source. The power control circuit is operable to connect and disconnect the power source from the circuit. The power control circuit connects the power source to the circuit in response to an externally applied magnetic field.
    Type: Application
    Filed: October 31, 2003
    Publication date: May 5, 2005
    Inventors: Timothy Connors, Geoffrey Lyon, Salil Pradhan
  • Publication number: 20040220103
    Abstract: The invention pertains to methods and compositions for treating medical disorders characterized by elevated levels or abnormal expression of TNF&agr; by administering a TNF&agr; antagonist, such as recombinant TNFR:Fc.
    Type: Application
    Filed: May 25, 2004
    Publication date: November 4, 2004
    Applicant: Immunex Corporation
    Inventors: Barbara K. Finck, Larry O'Neal, John D. Pluenneke, Timothy Connor
  • Publication number: 20030170244
    Abstract: The present invention relates to the general field of treating bone marrow failure and cancer. The invention, in part, utilizes inhibitors of Fas antigen (CD95) induced apoptosis to treat bone marrow failure and to improve cancer therapies.
    Type: Application
    Filed: December 12, 2002
    Publication date: September 11, 2003
    Inventors: John D. Pluenneke, Timothy Connor
  • Patent number: 6071717
    Abstract: The present invention involves isolated nucleic acid encoding human PKD1, and sequences derived therefrom. The invention also encompasses vectors comprising these nucleic acids, host cells transformed with the vectors, and methods for producing PKD1 protein or fragments thereof. In another aspect, the invention involves isolated oligonucleotides that hybridize only to the authentic expressed PKD1 gene, and not to PKD1 homologues. In yet another aspect, the invention involves isolated mutant PKD1 genes, and their cDNA cognates. Further provided are isolated oligonucleotides that discriminate between normal and mutant versions of the PKD1 gene. Methods and compositions for treating APKD or disease conditions having the characteristics of APKD are also provided.
    Type: Grant
    Filed: June 4, 1996
    Date of Patent: June 6, 2000
    Assignees: Genzyme Corporation, Johns Hopkins University
    Inventors: Katherine Klinger, Timothy Burn, Timothy Connors, William Dackowski, Gregory Germino, Feng Qian, Gregory Landes
  • Patent number: 6028173
    Abstract: This invention provides an isolated human netrin polypeptide. Netrins define a family of diffusable factors involved in axon outgrowth.
    Type: Grant
    Filed: June 17, 1996
    Date of Patent: February 22, 2000
    Assignee: Genzyme Corporation
    Inventors: Gregory Landes, Timothy Burn, Timothy Connors, William Dackowski, Terence Van Raay, Katherine Klinger